Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06282874
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-28
First Post:
2024-01-30
Brief Title:
Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
Sponsor:
Guangdong Association of Clinical Trials
Organization:
Guangdong Association of Clinical Trials
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-30
First Submit QC Date:
February 21 2024
Study First Post Date:
2024-02-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-21
Last Update Post Date:
2024-02-28
Last Update Post Date Type:
ACTUAL